Cancer
All Cancer articles
284 articles · showing 271–284
British Study: Older Women Need Pap Smears Every Five Years; Younger Women Every Three Years (dateline November 5, 2003)
The results of a study by British researchers finds that older women need to be screened for cervical cancer once every five years while younger women should undergo screening once every three years.
Researchers Explore Alternative to Pap Tests in Developing Countries (dateline August 18, 2003)
The rate of cervical cancer cases is far greater in less developed countries where women do not have adequate access to healthcare, and particularly to screening with Pap tests.
U.S. FDA Approves HPV Screening Test for Cervical Cancer (dateline August 8, 2003)
The U.S. Food and Drug Administration (FDA) recently approved the use of a screening test designed to detect the human papillomavirus (HPV), a sexually transmitted disease that can increase the risk of cervical cancer.
New Cervical Cancer Data Shows Downward Trend, But Cases Still High Among Older Women and Some Hispanics (dateline April 22, 2003)
While the incidence of cervical cancer has decreased in the United States as a whole, Hispanic women over 30 years of age are twice as likely to be diagnosed with the disease compared to non-Hispanic women.
Study: Smoking Increases Risk of Cervical Cancer in Women with HPV (dateline February 9, 2003)
A new study finds that women with HPV , a common sexually transmitted disease, are at significantly higher risk of developing cervical cancer if they smoke.
Research for Cervical Cancer Vaccine Promising (dateline February 6, 2003)
A study of a vaccine that targets one of the main causes of cervical cancer showed promising results, according to a report published in a recent issue of the New England Journal of Medicine.
New Guidelines for Evaluating Women with Abnormal Pap Test Results (dateline November 4, 2002)
New guidelines for investigating abnormal Pap test results were recently established by a panel of 121 experts from 29 professional organizations, federal agencies, and national and international health organizations in a conference sponsored by the American Society for Colposcopy and Cervical Patho
Major Update to Widely Used Classification System of Pap Test Results (dateline August 24, 2002)
The National Cancer Institute has announced a thorough update to the system used to classify Pap test results in more than 90% of laboratories across the United States as well as in several other countries.
Clinical Trial Will Investigate Possible Vaccine for Cervical Cancer (dateline December 5, 2001)
British researchers hope to enroll up to 20 women to test a vaccine that may help prevent cervical cancer. The vaccine is actually a modified version of the vaccine used to prevent smallpox, a disease that was virtually eradicated from the world in the 1970s.
Cone Biopsy Treatment May Help Early-Stage Cervical Cancer Patients Preserve Fertility (dateline November 19, 2001)
Most women who are diagnosed with early stage cervical cancer must undergo a hysterectomy, a treatment that results in permanent infertility.
Large Study Finds Prolonged Use Estrogen Replacement Therapy Increases Risk of Death from Ovarian Cancer (dateline March 22, 2001)
In a study of more than 200,000 women, researchers from the American Cancer Society found that using estrogen replacement therapy (ERT) for 10 or more years increases the risk of death from ovarian cancer.
Physicians and Women Often Ignore Early Signs of Ovarian Cancer (dateline November 20, 2000)
Physicians often call ovarian cancer the "silent killer" because the symptoms of the disease are believed to vague and sometimes nonexistent until advanced stages of the disease.
Study Finds New Treatment Option for Advanced Ovarian Cancer Patients (dateline June 1, 2000)
A preliminary study presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in May 2000 finds that weekly doses of the chemotherapy drug paclitaxel (brand name, Taxol) may benefit advanced ovarian cancer patients who have become resistant to standard chemotherapy with a c
BRCA Gene Mutations Put Women At Greater Risk for Ovarian Cancer But Also Increase Chances of Survival (Dateline May 5, 2000)
Women who have genetic mutations of the BRCA1 or BRCA2 gene are at an increased risk of developing ovarian cancer and breast cancer.